Published April 2012 | Version v1
Journal article

Tumor marker CYFRA 21-1 in assessment of radiation treatment efficacy at local non-small-cell lung cancer

  • 1. Grigoriev Institute for Medical Radiology, Kharkiv (Ukraine)

Description

The results of radiation therapy (RT) at various fractionation modes with Etopiside and Cysplatin modification in patients with non-small-cell lung cancer (NSCLC) are analyzed. The objective effect of accelerated RT was accompanied by statistically significant reduction of blood serum CYFRA 21-1 level (an index of proteolytic tumor degradation). It was established that the dynamics of blood serum CYFRA 21-1 expression coincided with the clinical findings and could be used for prognosis and monitoring of chemoradiation therapy efficacy in patients with NSCLC.

Additional details

Additional titles

Original title (Ukrainian)
Pukhlinnij marker CYFRA 21-1 v otsyintsyi efektivnostyi promenevogo lyikuvannya myistsevoposhirenikh form nedryibnoklyitinnogo raku legenyi

Publishing Information

Journal Title
Ukrayins'kij Radyiologyichnij Zhurnal
Journal Volume
20
Journal Issue
no.2
Journal Page Range
p. 124-126
ISSN
1027-3204

Conference

Title
Scientific and practical conference 'Current issues of Radiation and Combined Treatment of Cancer and Prevention of Complications'
Original Conference Title
Naukovo-praktichna konferentsyiya
Dates
21-22 May 2012
Place
Kharkiv (Ukraine)

INIS

Country of Publication
Ukraine
Country of Input or Organization
Ukraine
INIS RN
44116975
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
ANTIGENS; BIOLOGICAL MARKERS; BLOOD SERUM; EFFICIENCY; FRACTIONATED IRRADIATION; LUNGS; NEOPLASMS; PATIENTS; RADIOTHERAPY
Descriptors DEC
BIOLOGICAL MATERIALS; BLOOD; BLOOD PLASMA; BODY; BODY FLUIDS; DISEASES; IRRADIATION; MATERIALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY